271 related articles for article (PubMed ID: 7816677)
1. Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.
Greco KE; Kulawiak L
Oncol Nurs Forum; 1994 Oct; 21(9):1504-11. PubMed ID: 7816677
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
3. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
4. The cost of prostate cancer chemoprevention: a decision analysis model.
Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
Canby-Hagino ED; Thompson IM
Nat Clin Pract Oncol; 2005 May; 2(5):255-61. PubMed ID: 16264961
[TBL] [Abstract][Full Text] [Related]
7. [Prostate cancer prevention].
Wisard M; Leisinger HJ
Rev Med Suisse; 2006 Jan; 2(48):163-5. PubMed ID: 16463803
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hormone-related cancers: prostate cancer.
Parnes HL; Thompson IM; Ford LG
J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
[TBL] [Abstract][Full Text] [Related]
9. [Nutrition and pharmacological treatment for prevention of prostate cancer].
Segev Y; Nativ O
Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
11. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.
Goetzl MA; Holzbeierlein JM
Nat Clin Pract Urol; 2006 Aug; 3(8):422-9. PubMed ID: 16902518
[TBL] [Abstract][Full Text] [Related]
12. Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention.
Canby-Hagino E; Hernandez J; Brand TC; Thompson I
Eur Urol; 2007 Jan; 51(1):27-33. PubMed ID: 17030406
[TBL] [Abstract][Full Text] [Related]
13. Human prostate cancer risk factors.
Bostwick DG; Burke HB; Djakiew D; Euling S; Ho SM; Landolph J; Morrison H; Sonawane B; Shifflett T; Waters DJ; Timms B
Cancer; 2004 Nov; 101(10 Suppl):2371-490. PubMed ID: 15495199
[TBL] [Abstract][Full Text] [Related]
14. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
[TBL] [Abstract][Full Text] [Related]
15. Application of carcinogenesis theory to primary prevention.
Foltz AT; Mahon SM
Oncol Nurs Forum; 2000 Oct; 27(9 Suppl):5-11. PubMed ID: 11058978
[TBL] [Abstract][Full Text] [Related]
16. Men's perspectives on the impact of prostate cancer: implications for oncology nurses.
Fitch MI; Gray R; Franssen E; Johnson B
Oncol Nurs Forum; 2000 Sep; 27(8):1255-63. PubMed ID: 11013906
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.
Crawford ED; Andriole GL; Marberger M; Rittmaster RS
Urology; 2010 Mar; 75(3):502-9. PubMed ID: 20035983
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
19. The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies.
Unger JM; LeBlanc M; Thompson IM; Coltman CA
Urol Oncol; 2004; 22(4):362-8. PubMed ID: 15283898
[TBL] [Abstract][Full Text] [Related]
20. [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].
Villers A
Prog Urol; 2008 Apr; 18 Suppl 3():S58-62. PubMed ID: 18455086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
